Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients.
Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients.
复制标题
DOI:
10.1007/s10072-021-05744-8
复制
发表时间:
2022-01
期刊:
影响因子:
--
通讯作者:
Pistarini C
中科院分区:
文献类型:
--
作者:
Manera MR;Fiabane E;Pain D;Aiello EN;Radici A;Ottonello M;Padovani M;Wilson BA;Fish J;Pistarini C
The novel human coronavirus (SARS-CoV-2) shows neurotropism and systemically affects the central nervous system (CNS). Cognitive deficits have been indeed reported as both short- and long-term sequelae of SARS-CoV-2 infection. However, the association between these disturbances and background/disease-related clinical features remains elusive. This work aimed at exploring how post-infective cognitive status relates to clinical/treatment outcomes by controlling for premorbid/current risk factors for cognitive deficits. Cognitive measures (Mini-Mental State Examination, MMSE) of N=152 COVID-19 patient were retrospectively assessed in relation to disease severity, intensive care unit (ICU) admission, steroidal treatment, and occurrence of other viral/bacterial infections by controlling for remote/recent/COVID-19-related risk factors for cognitive deficits (at-risk vs. not-at-risk: Neuro+ vs. Neuro−). Descriptively, impaired MMSE performances were highly prevalent in mild-to-moderate patients (26.3%). ICU-admitted patients made less errors (p=.021) on the MMSE than those not admitted when partialling out risk factors and age—the latter negatively influencing performances. When addressing Neuro− patients only, steroidal treatment appears to improve MMSE scores among those suffering from other infections (p=.025). Cognitive sequelae of COVID-19 are likely to arise from a complex interplay between background/clinical premorbid features and disease-related/interventional procedures and outcomes. Mild-to-moderate patients requiring assistive ventilation who however are not admitted to an ICU are more likely to suffer from cognitive deficits—despite their etiology remaining elusive.
登录
查看更多内容
DOI:
10.2967/jnumed.121.262128
发表时间:
2021-07-01
期刊:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
影响因子:
--
作者:
Blazhenets G;Schroeter N;Bormann T;Thurow J;Wagner D;Frings L;Weiller C;Meyer PT;Dressing A;Hosp JA
通讯作者:
Hosp JA
影响因子:
4
作者:
Aiello EN;Gramegna C;Esposito A;Gazzaniga V;Zago S;Difonzo T;Maddaluno O;Appollonio I;Bolognini N
通讯作者:
Bolognini N
DOI:
10.1038/s41386-021-00978-8
发表时间:
2021-12
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
Jaywant A;Vanderlind WM;Alexopoulos GS;Fridman CB;Perlis RH;Gunning FM
通讯作者:
Gunning FM
DOI:
10.1007/s10072-020-04753-3
发表时间:
2020-11
期刊:
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
影响因子:
--
作者:
通讯作者:
--
影响因子:
3.4
作者:
Pistarini C;Fiabane E;Houdayer E;Vassallo C;Manera MR;Alemanno F
通讯作者:
Alemanno F